• Naomi Pearce & Emily Bristow

Pearce IP BioBlast: w/e 14 Feb 2020

  • On 11 February 2020, Amgen sued Hospira in the District Court of Delaware, alleging Hospira's aBLA for a proposed pegfilgrastim biosimilar infringes Amgen's Neulasta patent for protein purification (no. 8,273,707).

Biosimilars Bulletin 
Search by tags

© 2019 Pearce IP | Australia

  • LinkedIn Social Icon